HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Boulanger, E. Articles by Gessain, A. Search for Related Content PubMed PubMed Citation Articles by Boulanger, E. Articles by Gessain, A.

Extracavitary tumor after primary effusion lymphoma: relapse or second distinct lymphoma?

Service d’Immunopathologie Clinique, Département d’Immunologie Clinique, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP) (EB, EO); Laboratoire d’Anatomie Pathologique, Hôpital Saint-Louis, AP-HP (VM); Unité d’Epidémiologie et de Physiopathologie des Virus Oncogènes, Département de Virologie, Institut Pasteur (PVA, RD, AG); Laboratoire de Virologie, Hôpital Saint-Louis, AP-HP, Paris, France (FA)

Correspondence: Emmanuelle Boulanger, Département d’Immunologie Clinique, Hôpital Saint-Louis, 1 avenue Claude Vellefaux, 75 475 Paris cedex 10, France. Phone: international +33.142499690. Fax: international +33.14249 94 72. E-mail: emmanuelle.boulanger{at}sls.aphp.fr

HHV-8-associated solid lymphomas which develop in extracavitary sites during the course of primary effusion lymphoma (PEL) could represent the relapse of original PEL tumors in different anatomical sites, or newly occurring distinct HHV-8-associated lymphomas, such as multicentric Castleman disease-related microlymphomas. HHV-8 episome clonality might help identify which event takes place.

Key words: human herpesvirus 8, Kaposi sarcoma-associated herpesvirus, non-Hodgkin’s lymphoma, primary effusion lymphoma, human immunodeficiency virus type 1.